Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles

Selected Variant

HY-142042-01

Size: 5 mg

3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles is an inhibitor for bone morphogenetic protein 2 (BMP2) with an IC50 of 2.2 μM. 3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles is inhibitor for mitogen-activated protein kinase 1 (MEK1) . 3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles exhibits anti-inflammatory and neuroprotective activity in EAE mouse model[1][2].

Product Specifications

CAS Number

287196-91-2

UNSPSC

12352005

Target

MEK; TGF-beta/Smad

Type

Reference compound

Related Pathways

MAPK/ERK Pathway; Stem Cell/Wnt; TGF-beta/Smad

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles.html

Purity

99.84

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

N#CC1=C(NC2=CC=CC=C2C(F)(F)F)SNC1=O

Molecular Formula

C11H6F3N3OS

Molecular Weight

285.25

References & Citations

[1]Arnon KARNI, Small organic molecules for use in the treatment of neuroinflammatory disorders. WO2018198123.|[2]Varaprasad CV, et al., Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitors. Bioorg Med Chem Lett. 2006 Aug 1;16 (15) :3975-80.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Price

Sign In for Pricing

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog